REMS — Risk Evaluation and Mitigation Strategies

Claim

A REMS is an FDA drug safety program required for certain medicines with serious safety concerns to help ensure benefits outweigh risks. REMS reinforce specific safe-use actions (education, monitoring, restricted distribution) beyond ordinary labeling — only a minority of drugs have one.

Plain

REMS = extra FDA-required safety steps for a few high-risk drugs. Not every med has one. Follow the program’s certification / monitoring rules when it applies.

Citations

1. FDA — Risk Evaluation and Mitigation Strategies (REMS) (FDA REMS overview) — source
   

   A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.

   retrieved 2026-09-07